{"id":2523,"date":"2017-12-30T09:11:47","date_gmt":"2017-12-30T09:11:47","guid":{"rendered":"https:\/\/lynxee.consulting\/europe-consultation-publique-projet-de-guide-identifier-perturbateurs-endocriniens\/"},"modified":"2024-11-08T09:26:28","modified_gmt":"2024-11-08T09:26:28","slug":"europe-public-consultation-draft-guidance-identifying-eds","status":"publish","type":"post","link":"https:\/\/lynxee.consulting\/en\/europe-public-consultation-draft-guidance-identifying-eds\/","title":{"rendered":"EUROPE: Public consultation on draft guidance for identifying endocrine disruptors"},"content":{"rendered":"<p style=\"text-align: justify;\">ECHA and EFSA are inviting interested parties <a href=\"https:\/\/lnks.gd\/l\/eyJhbGciOiJIUzI1NiJ9.eyJlbWFpbCI6ImR1Zm91ci5yb2JlcnQxMUBnbWFpbC5jb20iLCJidWxsZXRpbl9saW5rX2lkIjoiMTA0Iiwic3Vic2NyaWJlcl9pZCI6IjM5MDcwMDU2MiIsImxpbmtfaWQiOiIzMDE2OTgwMDciLCJ1cmkiOiJicDI6ZGlnZXN0IiwidXJsIjoiaHR0cHM6Ly9jb21tZW50cy5lY2hhLmV1cm9wYS5ldS9Db21tZW50c19jbXMvUENfRURfR3VpZGFuY2UuYXNweD91dG1fY29udGVudD0mdXRtX21lZGl1bT1lbWFpbCZ1dG1fbmFtZT0mdXRtX3NvdXJjZT1nb3ZkZWxpdmVyeSZ1dG1fdGVybT0iLCJidWxsZXRpbl9pZCI6IjIwMTcxMjIwLjgyNzI5NDYxIn0.OX0MfK2TPBTuq8LHnYSk8nIx-36xyytjzKEawllEiA0\" target=\"_blank\" rel=\"noopener noreferrer\">to comment<\/a> on the draft guidance document for identifying endocrine disruptors. The deadline for providing comments is 31 January 2018.<\/p>\n<p style=\"text-align: justify;\">The European Commission will organise a workshop on 1-2 February 2018 to test the applicability of the draft guidance on the basis of case studies using active substances currently under assessment in the context of the pesticides and biocides Regulations. Two experts per Member State (one for pesticides, one for biocides) plus the speakers presenting selected case studies will be reimbursed. Stakeholders will also be invited.<\/p>\n<p style=\"text-align: justify;\">The final guidance will be applicable to both biocides and pesticides, provided that the criteria that will in the end be adopted for pesticides will not substantially differ from those adopted for biocides.<\/p>\n<p style=\"text-align: justify;\">As quoted in our previous article, the European Parliament voted to object to the European Commission\u2019s draft regulation setting out criteria for identifying endocrine disruptors in the area of plant protection products (PPPs) in October 2017. In the meantime, the European Commission put to a vote a new proposal for EDs definition at the PAFF meeting of 12-13 December 2017 (<a href=\"https:\/\/ec.europa.eu\/health\/sites\/health\/files\/endocrine_disruptors\/docs\/201712_ppp_draft_en.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">SANTE\/11992\/2017<\/a>). \u00a0The revised draft Regulation is identical to the text voted in July, except for the deletion of the last paragraph with the provision on the growth regulators and the corresponding Recital. The revised draft Regulation thus followed exactly the request of the European Parliament. A favourable opinion with qualified majority (18 Member States in favour, representing 65.79 % of the EU population) was given. The draft Regulation would now be sent to the Council and the European Parliament. They will have 3 months to examine it before final adoption by the Commission.<\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>To download:<\/strong> \u00a0<a href=\"https:\/\/comments.echa.europa.eu\/Comments_cms\/ED_Guidance%20for%20public%20consultation_20171207.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Draft guidance for identifying endocrine disruptors<\/a><\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>See also our previous article:<\/strong> <a href=\"https:\/\/lynxee.consulting\/en\/europe-parliament-rejects-criteria-for-endocrine-disruptors\/\" target=\"_blank\" rel=\"noopener noreferrer\">EUROPE: Parliament rejects criteria for endocrine disruptors<\/a><\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Lynxee consulting\u2019s team<\/strong> is at your disposal to answer your questions.<\/p>\n<p style=\"text-align: justify;\"><strong>Contact us!<\/strong> <a href=\"https:\/\/lynxee.consulting\/en\/contact\/\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/lynxee.consulting\/en\/contact\/<\/a><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<h6>Photo credit: OpenClipart-Vectors\/pixabay<\/h6>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>ECHA and EFSA are inviting interested parties to comment on the draft guidance document for identifying endocrine disruptors. The deadline for providing comments is 31 January<span class=\"excerpt-hellip\"> [\u2026]<\/span><\/p>\n","protected":false},"author":5,"featured_media":7617,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[36],"tags":[118,181],"class_list":["post-2523","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-regulation","tag-endocrine-disruptors","tag-perturbateurs-endocriniens-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>EUROPE: Public consultation on draft guidance for identifying endocrine disruptors - Lynxee consulting<\/title>\n<meta name=\"description\" content=\"ECHA and EFSA are inviting interested parties to comment on the draft guidance document for identifying endocrine disruptors. The deadline for providing\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/lynxee.consulting\/en\/europe-public-consultation-draft-guidance-identifying-eds\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EUROPE: Public consultation on draft guidance for identifying endocrine disruptors - Lynxee consulting\" \/>\n<meta property=\"og:description\" content=\"ECHA and EFSA are inviting interested parties to comment on the draft guidance document for identifying endocrine disruptors. The deadline for providing\" \/>\n<meta property=\"og:url\" content=\"https:\/\/lynxee.consulting\/en\/europe-public-consultation-draft-guidance-identifying-eds\/\" \/>\n<meta property=\"og:site_name\" content=\"Lynxee consulting\" \/>\n<meta property=\"article:published_time\" content=\"2017-12-30T09:11:47+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-08T09:26:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/lynxee.consulting\/wp-content\/uploads\/2015\/10\/neuron-160944_1280.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"960\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Karine Mavet\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Karine Mavet\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/europe-public-consultation-draft-guidance-identifying-eds\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/europe-public-consultation-draft-guidance-identifying-eds\\\/\"},\"author\":{\"name\":\"Karine Mavet\",\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/#\\\/schema\\\/person\\\/a2a6161ec6591c6ae990f836d8ae4f63\"},\"headline\":\"EUROPE: Public consultation on draft guidance for identifying endocrine disruptors\",\"datePublished\":\"2017-12-30T09:11:47+00:00\",\"dateModified\":\"2024-11-08T09:26:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/europe-public-consultation-draft-guidance-identifying-eds\\\/\"},\"wordCount\":330,\"image\":{\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/europe-public-consultation-draft-guidance-identifying-eds\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/lynxee.consulting\\\/wp-content\\\/uploads\\\/2015\\\/10\\\/neuron-160944_1280.png\",\"keywords\":[\"endocrine disruptors\",\"perturbateurs endocriniens\"],\"articleSection\":[\"Regulation\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/europe-public-consultation-draft-guidance-identifying-eds\\\/\",\"url\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/europe-public-consultation-draft-guidance-identifying-eds\\\/\",\"name\":\"EUROPE: Public consultation on draft guidance for identifying endocrine disruptors - Lynxee consulting\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/europe-public-consultation-draft-guidance-identifying-eds\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/europe-public-consultation-draft-guidance-identifying-eds\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/lynxee.consulting\\\/wp-content\\\/uploads\\\/2015\\\/10\\\/neuron-160944_1280.png\",\"datePublished\":\"2017-12-30T09:11:47+00:00\",\"dateModified\":\"2024-11-08T09:26:28+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/#\\\/schema\\\/person\\\/a2a6161ec6591c6ae990f836d8ae4f63\"},\"description\":\"ECHA and EFSA are inviting interested parties to comment on the draft guidance document for identifying endocrine disruptors. The deadline for providing\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/europe-public-consultation-draft-guidance-identifying-eds\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/lynxee.consulting\\\/en\\\/europe-public-consultation-draft-guidance-identifying-eds\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/europe-public-consultation-draft-guidance-identifying-eds\\\/#primaryimage\",\"url\":\"https:\\\/\\\/lynxee.consulting\\\/wp-content\\\/uploads\\\/2015\\\/10\\\/neuron-160944_1280.png\",\"contentUrl\":\"https:\\\/\\\/lynxee.consulting\\\/wp-content\\\/uploads\\\/2015\\\/10\\\/neuron-160944_1280.png\",\"width\":1280,\"height\":960},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/europe-public-consultation-draft-guidance-identifying-eds\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EUROPE: Public consultation on draft guidance for identifying endocrine disruptors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/#website\",\"url\":\"https:\\\/\\\/lynxee.consulting\\\/\",\"name\":\"Lynxee consulting\",\"description\":\"Innovative support for regulatory issues\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/lynxee.consulting\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/#\\\/schema\\\/person\\\/a2a6161ec6591c6ae990f836d8ae4f63\",\"name\":\"Karine Mavet\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/wp-content\\\/uploads\\\/2015\\\/05\\\/karine-96x96.jpg\",\"url\":\"https:\\\/\\\/lynxee.consulting\\\/wp-content\\\/uploads\\\/2015\\\/05\\\/karine-96x96.jpg\",\"contentUrl\":\"https:\\\/\\\/lynxee.consulting\\\/wp-content\\\/uploads\\\/2015\\\/05\\\/karine-96x96.jpg\",\"caption\":\"Karine Mavet\"},\"sameAs\":[\"https:\\\/\\\/lynxee.consulting\"],\"url\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/author\\\/karine\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EUROPE: Public consultation on draft guidance for identifying endocrine disruptors - Lynxee consulting","description":"ECHA and EFSA are inviting interested parties to comment on the draft guidance document for identifying endocrine disruptors. The deadline for providing","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/lynxee.consulting\/en\/europe-public-consultation-draft-guidance-identifying-eds\/","og_locale":"en_US","og_type":"article","og_title":"EUROPE: Public consultation on draft guidance for identifying endocrine disruptors - Lynxee consulting","og_description":"ECHA and EFSA are inviting interested parties to comment on the draft guidance document for identifying endocrine disruptors. The deadline for providing","og_url":"https:\/\/lynxee.consulting\/en\/europe-public-consultation-draft-guidance-identifying-eds\/","og_site_name":"Lynxee consulting","article_published_time":"2017-12-30T09:11:47+00:00","article_modified_time":"2024-11-08T09:26:28+00:00","og_image":[{"width":1280,"height":960,"url":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2015\/10\/neuron-160944_1280.png","type":"image\/png"}],"author":"Karine Mavet","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Karine Mavet","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/lynxee.consulting\/en\/europe-public-consultation-draft-guidance-identifying-eds\/#article","isPartOf":{"@id":"https:\/\/lynxee.consulting\/en\/europe-public-consultation-draft-guidance-identifying-eds\/"},"author":{"name":"Karine Mavet","@id":"https:\/\/lynxee.consulting\/#\/schema\/person\/a2a6161ec6591c6ae990f836d8ae4f63"},"headline":"EUROPE: Public consultation on draft guidance for identifying endocrine disruptors","datePublished":"2017-12-30T09:11:47+00:00","dateModified":"2024-11-08T09:26:28+00:00","mainEntityOfPage":{"@id":"https:\/\/lynxee.consulting\/en\/europe-public-consultation-draft-guidance-identifying-eds\/"},"wordCount":330,"image":{"@id":"https:\/\/lynxee.consulting\/en\/europe-public-consultation-draft-guidance-identifying-eds\/#primaryimage"},"thumbnailUrl":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2015\/10\/neuron-160944_1280.png","keywords":["endocrine disruptors","perturbateurs endocriniens"],"articleSection":["Regulation"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/lynxee.consulting\/en\/europe-public-consultation-draft-guidance-identifying-eds\/","url":"https:\/\/lynxee.consulting\/en\/europe-public-consultation-draft-guidance-identifying-eds\/","name":"EUROPE: Public consultation on draft guidance for identifying endocrine disruptors - Lynxee consulting","isPartOf":{"@id":"https:\/\/lynxee.consulting\/#website"},"primaryImageOfPage":{"@id":"https:\/\/lynxee.consulting\/en\/europe-public-consultation-draft-guidance-identifying-eds\/#primaryimage"},"image":{"@id":"https:\/\/lynxee.consulting\/en\/europe-public-consultation-draft-guidance-identifying-eds\/#primaryimage"},"thumbnailUrl":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2015\/10\/neuron-160944_1280.png","datePublished":"2017-12-30T09:11:47+00:00","dateModified":"2024-11-08T09:26:28+00:00","author":{"@id":"https:\/\/lynxee.consulting\/#\/schema\/person\/a2a6161ec6591c6ae990f836d8ae4f63"},"description":"ECHA and EFSA are inviting interested parties to comment on the draft guidance document for identifying endocrine disruptors. The deadline for providing","breadcrumb":{"@id":"https:\/\/lynxee.consulting\/en\/europe-public-consultation-draft-guidance-identifying-eds\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/lynxee.consulting\/en\/europe-public-consultation-draft-guidance-identifying-eds\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/lynxee.consulting\/en\/europe-public-consultation-draft-guidance-identifying-eds\/#primaryimage","url":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2015\/10\/neuron-160944_1280.png","contentUrl":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2015\/10\/neuron-160944_1280.png","width":1280,"height":960},{"@type":"BreadcrumbList","@id":"https:\/\/lynxee.consulting\/en\/europe-public-consultation-draft-guidance-identifying-eds\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/lynxee.consulting\/en\/"},{"@type":"ListItem","position":2,"name":"EUROPE: Public consultation on draft guidance for identifying endocrine disruptors"}]},{"@type":"WebSite","@id":"https:\/\/lynxee.consulting\/#website","url":"https:\/\/lynxee.consulting\/","name":"Lynxee consulting","description":"Innovative support for regulatory issues","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/lynxee.consulting\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/lynxee.consulting\/#\/schema\/person\/a2a6161ec6591c6ae990f836d8ae4f63","name":"Karine Mavet","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2015\/05\/karine-96x96.jpg","url":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2015\/05\/karine-96x96.jpg","contentUrl":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2015\/05\/karine-96x96.jpg","caption":"Karine Mavet"},"sameAs":["https:\/\/lynxee.consulting"],"url":"https:\/\/lynxee.consulting\/en\/author\/karine\/"}]}},"_links":{"self":[{"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/posts\/2523","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/comments?post=2523"}],"version-history":[{"count":4,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/posts\/2523\/revisions"}],"predecessor-version":[{"id":7620,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/posts\/2523\/revisions\/7620"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/media\/7617"}],"wp:attachment":[{"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/media?parent=2523"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/categories?post=2523"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/tags?post=2523"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}